Nomination Summary for Saw palmetto extract (N97009)

Nominated Substances: Saw palmetto extract, Saw palmetto and beta-sitosterol mixture, beta-Sitosterol

Nomination Date: 05/12/1997

Nominator: Private Individual

Rationale: Saw palmetto is an herbal dietary supplement being widely promoted as a prostate hypertrophy preventative agent, and as a therapy for this condition. Some clinical data show beneficial effects greater than those from prescription medications, with very good tolerance. The use of saw palmetto continues to grow based on favorable press stories. It is not known whether long term or carcinogenicity testing has been performed in animals; no data were found.

NTP Principles: 2, 3

Status: Deferred


Agents and Status

The following information relates to the specific agent and may include history from earlier or later nominations for this same agent.


CASRN: 84604-15-9

Agent Name: Saw palmetto extract

  • No studies are available.

CASRN: SAWPALMETMIX

Agent Name: Saw palmetto and beta-sitosterol mixture

  • No studies are available.

CASRN: 83-46-5

Agent Name: beta-Sitosterol